Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ýíäîêðèíîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé ýíäîêðèíîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 19.03.2017, 14:10
camelot camelot âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.08.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 1,628
Ñêàçàë(à) ñïàñèáî: 171
Ïîáëàãîäàðèëè 477 ðàç(à) çà 471 ñîîáùåíèé
camelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
À äî êàêîãî ðîñòà îíà õî÷åò åãî äîðàñòèòü? Ìàëî 185ñì?
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 19.03.2017, 15:49
ELENA_VLAD ELENA_VLAD âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 24.07.2008
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 7,005
Ñêàçàë(à) ñïàñèáî: 278
Ïîáëàãîäàðèëè 2,154 ðàç(à) çà 2,079 ñîîáùåíèé
ELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íåò, òåïåðü âñå ñôîðìèðîâàëè, íî ðåàëüíàÿ ïðîáëåìà ñ âûïèñêîé àíäðîãåíîâ. Îíà ìå÷åòñÿ ìåæäó âðà÷àìè - òî ÕÃ, òî àíäðîãåíû.... Ïàðåíü ìíå ïîíðàâèëñÿ - ó íåãî îäíà ïðîáëåìà - çàèêàíèå, ýíäîêðèííûå çà ïðîáëåìû íå ñ÷èòàåò. Ýêòîïèþ ãèïîôèçà ÿâïåðâûå âñòðåòèëà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 20.03.2017, 16:20
ghrh44 ghrh44 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 21.07.2014
Ãîðîä: N-sk
Ñîîáùåíèé: 4,017
Ïîáëàãîäàðèëè 2,060 ðàç(à) çà 1,904 ñîîáùåíèé
ghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ELENA_VLAD Ïîñìîòðåòü ñîîáùåíèå
Õîòåëîñü áû íåñêîëüêî ññûëîê î áåñïîëåçíîñòè ãîðìîíà ðîñòà ó âçðîñëûõ! ïîäñêàæèòå, ïîæàëóéñòà!
Ñàìîå ïðîñòåíüêîå, - íà÷íèòå ñ åòîãî: è ìåòàáîëè÷åñêèé ñèíäðîì, è ñèëà ìûøö, è êà÷åñòâî æèçíè.. Ïëþñ , - òî, ÷òî ñäåëàíî áûëî êaê double-blind, placebo-controlled design.

J Clin Endocrinol Metab. 2004 May;89(5):2048-56.
Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.

Hoffman AR1, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO, Vance ML.



Åñòü åø¸ îäíà ñòàòüÿ ñ òåì æå ïåðâûì àâòîðîì, òîãî æå ãîäà, íî ñäåëaía â îòêðûòóþ: çíà÷èòåëüíîå óëó÷øåíèå êà÷åñòâà æèçíè:-)

J Clin Endocrinol Metab. 2004 Jul;89(7):3224-33.
Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing.

Hoffman AR1, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML; T002 Study Group.
__________________
Dr.B
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 20.03.2017, 17:17
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òàê ýòî æ ïðî áåíåôèòû ó âçðîñëûõ ñ äåôèöèòîì ÃÐ (1 ñëó÷àé íà 100 000 â ãîä â ÑØÀ, èç êîòîðûõ 15-20% - ïåðåõîä èç äåòñêîé ïîïóëÿöèè), à íàì íàäî ïðî âðåä ó âçðîñëûõ áåç äåôèöèòà îíîãî, ò.å. áåç ïîêàçàíèé ê ÃÐ.

Êîíå÷íî, åñëè äåôèöèò ÃÐ ïîäòâåðæä¸í, êàê [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ], òî çàìåñòèòåëüíàÿ òåðàïèÿ îáîñíîâàííà.
Öèòàòà:
GH deficiency is diagnosed by a low level of serum insulinlike growth factor-1 (IGF-1) in the presence of deficiency of 3 or more pituitary hormones. [24]
Patients who have deficiency of 2 or fewer pituitary hormones or pituitary/hypothalamic disease with low IGF-I levels require stimulation tests to establish the diagnosis of GH deficiency. The two most commonly used tests are the insulin tolerance test (ITT) and the combination of growth hormone-releasing hormone (GHRH) and arginine (GHRH-arginine test). The glucagon stimulation test is a third option.
Íî êòî òóò áóäåò ýòèì çàíèìàòüòñÿ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 20.03.2017, 21:12
ghrh44 ghrh44 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 21.07.2014
Ãîðîä: N-sk
Ñîîáùåíèé: 4,017
Ïîáëàãîäàðèëè 2,060 ðàç(à) çà 1,904 ñîîáùåíèé
ghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïåðâàÿ ññûëêà êàê ðàç ïðî âçðîñëûõ ñ äåôèöèòîì ÃÐ.

 òîì-òî è ôèøêà, ÷òî ÃÐ íå ïðèíîñèò íèêàêîé ïîëüçû âçðîñëûì ñ ïðèîáðåò¸ííûì íåäîñòàòêîì åãî.
Î äåòÿõ ñ íèçêèì ðîñòîì ñïîðó íåò: èì îí ïîêàçàí.
Î ïðèìåíåíèè åãî ó âçðîñëûõ áåç äåôèöèòà ÃÐ Âû ñàìè óæå ãîâîðèëè è äàâàëè ññûëêè.
 ïåðåõîäå îò äåòñêîãî äî âçðîñëîãî âîçðàñòà ñ äåôèöèòîì ÃÐ íåò õîðîøèõ äàííûõ, íî ëîãè÷íî ïðåäïîëîæèòü, ÷òî êàêàÿ- òî ïðîïîðöèÿ èç íèõ ìîæåò åãî ïîëó÷àòü ñ ïîëüçîé äëÿ ñåáÿ ïàðó ëåò äî çàêðûòèÿ êîñòåé.
Èíòåðåñíî, ÷òî äàæå ñàìûå ïðèâåðæåííûå ïðîïèñûâàòåëè ÃÐ äåòÿì ñ âðîæä¸ííûì äåôèöèòîì åãî îòìå÷àþò, ÷òî ñ òî÷êè çðåíèÿ êà÷åñòâà æèçíè îíè íå ñòðàäàþò. Îíî íèçêî ó äåòåé ïîñëå ðàäèàöèè è/èëè ñ ìíîæåñòâåííîé ãèïîôèçàðíîé íåäîñòàòî÷íîñòüþ, åñëè èõ ëå÷àò ñëèøêîì áîëüøèìè äîçàìè ñòåðîèäîâ è çàìåøàþò îñòàëüíûå ïðàâèëüíî.

À åñëè ìû áåð¸ì âçðîñëûõ ñ ïðèîáðåò¸ííûì ãèïîïèòóèòàðèçìîì, íåëå÷åííûõ ÃÐ, áåç èñòîðèè ðàäèàöèè è íà "íèçêèõ" äîçàõ ãèäðîêîðòèçîíà, ( 10-20 ìã/äåíü), òî êà÷åñòâî æèçíè ó íèõ àáñîëþòíî íå îòëè÷àåòñÿ îò çäîðîâûõ òîãî-æå âîçðàñòà.

ß êàê ðàç îá ýòîì è áóäó ãîâîðèòü íà ñüåçäå ÷åðåç 10 äíåé:-)

Êîììåíòàðèè ê ñîîáùåíèþ:
Samitin îäîáðèë(à):
__________________
Dr.B
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 21.03.2017, 04:20
ELENA_VLAD ELENA_VLAD âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 24.07.2008
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 7,005
Ñêàçàë(à) ñïàñèáî: 278
Ïîáëàãîäàðèëè 2,154 ðàç(à) çà 2,079 ñîîáùåíèé
ELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ëþäè, êîòîðûì ðåêîìåíäóþò íåêèå äîêòîðà â ðàçðåçå ìîäíîé òåðàïèè "ànti - aging" - âîîáùå èñõîäíî çäîðîâû!
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 21.03.2017, 09:31
Àâàòàð äëÿ ElenaSS11
ElenaSS11 ElenaSS11 âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 07.06.2009
Ãîðîä: Èðêóòñê
Ñîîáùåíèé: 311
Ñêàçàë(à) ñïàñèáî: 39
Ïîáëàãîäàðèëè 62 ðàç(à) çà 61 ñîîáùåíèé
ElenaSS11 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåElenaSS11 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ê íàì â ãîðîä 6 àïðåëÿ ïðèåçæàåò Ñîòíèêîâà ËÑ (Òîìñê), ó÷àñòâóþò â ïðèâîçå 4 ôàðìêîìïàíèè (ïðîìîìåä, ýááîò, ïôàéçåð è áèîíîðèêà). Ñòîèìîñòü êóðñà çíà÷èòåëüíî äåøåâëå )))) "âñåãî" 5 000 ðóá. Îáåùàåòñÿ ìàñòåð êëàññ ïî ýíäîêðèííîé ãèíåêîëîãèè - "áóäåò ïðåäñòàâëåí îïûò ðàáîòû íàó÷íî-êëèíè÷åñêîãî öåíòðà ãîðìîíàëüíîãî çäîðîâüÿ ïî íàïðàâëåíèþ anti-age ìåäèöèíû" (êîíåö öèòàòû)

 ïðîãðàììå óêàçàí ìýëñìîí

Èíòåðåñíî, ìíîãî ïîñåòèò âðà÷åé ?....
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 26.03.2017, 13:11
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ßÌÀ îïóáëèêîâàë ñòàòüþ ïðî òèïîâîé ìåõàíèçì íàñàæäåíèÿ òåñòîñòåðîíà: Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013 (JAMA. 2017;317(11):1159-1166. doi:10.1001/jama.2016.21041), [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ].
Êðàòêîå îïèñàíèå ñ Êàðäèîáðèôà ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]):
Öèòàòà:
Although testosterone is approved only for men with pathological hypogonadism, the pharmaceutical industry spent years promoting its much broader use as a "lifestyle" drug in men despite an absence of evidence for either safety or efficacy.
Öèòàòà:
Testosterone uptake correlated closely with advertising intensity. The authors calculated that each commercial resulted in an increase in new testosterone testing, new initiation of treatment, and even new initiation of treatment without a recent test. Each individual television ad was associated with an increase in 0.14 tests, 0.05 new initiations, and 0.02 initiations without a recent test per 10,000 men exposed to the ad.

Although the increase associated with each individual advertisement was small, the cumulative effect was quite large, since "advertisements were widespread and frequent during the study period; with cumulative ad exposures of close to 200" in some markets, the researchers said.
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 26.03.2017, 16:24
ghrh44 ghrh44 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 21.07.2014
Ãîðîä: N-sk
Ñîîáùåíèé: 4,017
Ïîáëàãîäàðèëè 2,060 ðàç(à) çà 1,904 ñîîáùåíèé
ghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òåñòèðîâàíèå òåñòîñòåðîíà êðîâè ó ãèïîãîíàäàëüíûõ ìóæ÷èí äîøëî äî àáñóðäà. Ìû òåïåðü äîëæíû ýòî äåëàòü êàæäîå îáíîâëåíèå ðåöåïòà. ß ïî ýòîìó ïîâîäó ãîâîðèë ñ âðà÷îì ñòðàõîâîé êîìïàíèè , êîòîðûé äîëæåí äàòü ñâî¸ "äîáðî". Ðå÷ü øëà î ìîèõ ãèïîïèòàõ: õðîíè÷åñêèé è íåèçëå÷èìûé äåôèöèò ãîðìîíà. Åñëè òåñòîñòåðîí íèçîê, îí óòâåðæäàåò îáíîâëåíèå ( åñòü ïîêàçàíèå); åñëè íîðìàëåí, òî îí òîæå óòâåðæäàåò ( äîçà õîðîøà). ß ñïðîñèë, òàê êàêîé ñìûñë â òåñòèðîâàíèè? Îí çàäóìàëñÿ è çàìîë÷àë..... îòâåòèë: "åñòü ïðàâèëà". Ìîå ïðåäëîæåíèå â ñàìîì íà÷àëå ëå÷åíèÿ ââåñòè íà ïðîøåíèè ïóíêòèê " ïîæèçíåííîå çàìåùåíèå èç-çà íåîáðàòèìîñòè áîëåçíè" åãî íå óáåäèëî: "åñòü ïðàâèëà":-)
Áûëî áû ñìåøíî, åñëè áû íå íàäî áûëî êàæäûé ãîä íàì çàïîëíÿòü áóìàãè, áîëüíîìó òðàòèòü âðåìÿ è íåðâû, à êîìïàíèè ïëàòèòü çà íåíóæíûé òåñò.

Áþðîêðàòèÿ ïðàâèò ìèðîì.
__________________
Dr.B
Îòâåòèòü ñ öèòèðîâàíèåì
  #25  
Ñòàðûé 26.03.2017, 17:15
ELENA_VLAD ELENA_VLAD âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 24.07.2008
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 7,005
Ñêàçàë(à) ñïàñèáî: 278
Ïîáëàãîäàðèëè 2,154 ðàç(à) çà 2,079 ñîîáùåíèé
ELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îêàçûâàåòñÿ, íå ó íàñ îäíèõ! Ìíå î÷åíü æàëü ýòèõ ïàöèåíòîâ - ÷àñòî èç-çè ïðîáëåì ñ âûïèñêîé ðåöåïòîâ îíè íå ëå÷àòñÿ êàê ïîëîæåíî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #26  
Ñòàðûé 26.03.2017, 18:42
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ghrh44 Ïîñìîòðåòü ñîîáùåíèå
Îí çàäóìàëñÿ è çàìîë÷àë..... îòâåòèë: "åñòü ïðàâèëà"..
Ïðàâèëüíûé îòâåò áûë: "...à åñëè äîçà íåïîäõîäÿùàÿ?". Õî÷ó áûòü ýêñïåðòîì.
Îòâåòèòü ñ öèòèðîâàíèåì
  #27  
Ñòàðûé 29.03.2017, 09:45
ELENA_VLAD ELENA_VLAD âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 24.07.2008
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 7,005
Ñêàçàë(à) ñïàñèáî: 278
Ïîáëàãîäàðèëè 2,154 ðàç(à) çà 2,079 ñîîáùåíèé
ELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
 êîíöå âèòàìèí Ä ....

Êîììåíòàðèè ê ñîîáùåíèþ:
Samitin îäîáðèë(à): Ñêîðî íà÷íóò äîìîé íàçâàíèâàòü ïîòåíöèàëüíûì ïàöèåíòàì, êàê äåëàþò â ÑØÀ...
Îòâåòèòü ñ öèòèðîâàíèåì
  #28  
Ñòàðûé 29.03.2017, 14:30
ghrh44 ghrh44 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 21.07.2014
Ãîðîä: N-sk
Ñîîáùåíèé: 4,017
Ïîáëàãîäàðèëè 2,060 ðàç(à) çà 1,904 ñîîáùåíèé
ghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåghrh44 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
 íà÷àëå 20-ãî âåêà ýíäîêðèíîëîãèÿ ñ÷èòàëàñü øàðëàòàíñêîé îáëàñòüþ ìåäèöèíû.
Ðåïóòàöèþ íàóêè îíà çàðàáîòàëà òÿæåëî, íî çàñëóæåííî.
Òåïåðü "ïðîôåññîð Êàëèí÷åíêî" è åé ïîäîáíûå óñïåøíî âîçâðàùàþò åå â ïåðâîáûòíîå ñîñòîÿíèå. Íî áàáëî äåëàþò ñåðü¸çíîå.

Êîììåíòàðèè ê ñîîáùåíèþ:
Melnichenko îäîáðèë(à):
__________________
Dr.B
Îòâåòèòü ñ öèòèðîâàíèåì
  #29  
Ñòàðûé 14.06.2017, 14:38
camelot camelot âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.08.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 1,628
Ñêàçàë(à) ñïàñèáî: 171
Ïîáëàãîäàðèëè 477 ðàç(à) çà 471 ñîîáùåíèé
camelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êîëëåãè, èç ëþáîãî àáñóðäà õî÷åòñÿ âûòàùèòü ðàöèîíàëüíîå çåðíî. Êàê âû îòíîñèòåñü ê ìíåíèþ, ÷òî êóðñû àíäðîãåíîâ ó æåíùèí çíà÷èòåëüíî óëó÷øàþò òàêîå ñîñòîÿíèå êàê ïðîëàïñ ãåíèòàëèé? Ýòî äåéñòâèòåëüíî î÷åíü íàáîëåâøàÿ ïðîáëåìà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #30  
Ñòàðûé 14.06.2017, 14:49
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Áîþñü, çäåñü ÿ ñîâñåì íå Êîïåíãàãåí. Ìíå êàê-òî ïîïàäàëîñü óïîìèíàíèå î òîïè÷åñêèõ ýñòðîãåíàõ êàê êîìïîíåíòå ëå÷åíèÿ ïðè ïðîëàïñå ìàòêè, íî îá àíäðîãåíàõ ïîäîáíîãî íå âñòðå÷àë. Íàäî ïîèñêàòü.
Íó èëè ïîäîæäàòü êîììåíòàðèÿ íàøèõ êîðèôååâ

Êîììåíòàðèè ê ñîîáùåíèþ:
camelot îäîáðèë(à): ïîèùåì è ïîäîæäåì!
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 12:40.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.